Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in

Pei-Chieh Tien1, Xiyue Chen1, Bennett D Elzey2,3

  • 1Department of Animal Sciences, Purdue University, West Lafayette, IN, 47907, USA.

Oncogene
|July 11, 2023
PubMed

Insights

Notch signaling activation in dedifferentiated liposarcoma (DDLPS) suppresses PGC-1α, inhibiting mitochondrial function and promoting cancer growth. Restoring PGC-1α reverses these effects, offering a potential therapeutic target for this lethal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Dedifferentiated liposarcoma (DDLPS) is a rare, lethal cancer lacking identified driver mutations, hindering targeted therapy development.
  • Constitutive Notch signaling activation, via Notch1 intracellular domain overexpression (NICDOE), in murine adipocytes models human DDLPS.
  • The precise mechanisms of Notch activation's oncogenic role in DDLPS remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Notch signaling drives DDLPS.
  • To investigate the link between Notch activation, cellular metabolism, and prognosis in DDLPS.
  • To identify potential therapeutic targets for DDLPS based on Notch signaling pathways.

Main Methods:

  • Analysis of Notch signaling activation in human DDLPS patient samples.
  • Metabolic profiling of murine NICDOE DDLPS cells using respirometry and glycolysis assays.
  • Genetic manipulation to ablate NICDOE or overexpress PGC-1α in DDLPS cells.
  • Assessment of mitochondrial biogenesis, cell growth, and adipogenic differentiation.

Main Results:

  • Notch signaling is activated in a subset of human DDLPS, correlating with poor prognosis and MDM2 expression.
  • Murine NICDOE DDLPS cells exhibit reduced mitochondrial respiration and increased glycolysis (Warburg effect).
  • Notch activation diminishes peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) expression, a key regulator of mitochondrial biogenesis.
  • Genetic rescue of NICDOE or PGC-1α overexpression restored mitochondrial function, inhibited tumor growth, and promoted adipogenic differentiation.

Conclusions:

  • Notch signaling activation in DDLPS suppresses PGC-1α, leading to impaired mitochondrial biogenesis and a metabolic shift towards glycolysis.
  • Restoration of PGC-1α function can reverse the metabolic and proliferative phenotypes of DDLPS.
  • Targeting the Notch-PGC-1α axis represents a promising therapeutic strategy for DDLPS.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K